reward points

Product details

Legal Category:  POM-V

In order to purchase Prescription Medicines you will need to supply evidence of your prescription. 

Each 10 g sachet contains the active substance Suxibuzone (microencapsulated) 1.5 g


Granules for top dressing use. Yellow and odourless granules


Treatment of pain and inflammation associated with musculo-skeletal conditions in the horse e.g. osteoarthritic conditions, bursitis, laminitis and soft tissue inflammation.

Dosage and administration:

For oral administration.

When added to a portion of feed the product will be accepted by most horses.

The following should be used as a guide, according to individual response:


For a 480 kg bodyweight horse, the contents of 2 sachets should be administered twice daily (equivalent to 12.5 mg of suxibuzone/kg/day) for 2 days, followed by 1 sachet twice daily (6.25 mg of suxibuzone/kg/day) for 3 days.  Thereafter, 1 sachet daily (3.1 mg of suxibuzone/kg/day) or on alternate days, or the minimum dose necessary for a satisfactory clinical response.


Ponies should receive only half the dose rate recommended for horses.  For a 240 kg bodyweight pony, the contents of 1 sachet should be administered daily (equivalent to 6.25 mg of suxibuzone/kg/day) for 2 days, followed by 1/2 sachet daily (3.1 mg of suxibuzone/kg/day) for 3 days or 1 sachet on alternate days.  Thereafter, reduce the dose to the minimum dose necessary for a satisfactory clinical response.

For administration of less than one sachet, use the measuring scoop provided. One full level scoop contains 5 g granules (equivalent to 1/2 sachet) and up to the green line level contains 2,5 g granules (equivalent to 1/4 sachet).

Hay, as part of the diet, may delay the absorption of suxibuzone and so the onset of clinical effect. It is advisable not to feed hay immediately prior to, or with DANILON equidos.

If no clinical response is evident after 4-5 days, discontinue treatment and reconsider the diagnosis.

Horses: Not for use in horses intended for human consumption. Treated horses should never be slaughtered for human consumption. The horse must be declared as not intended for human consumption under national horse passport regulation.

For further product information please click here. This link will take you to the Veterinary Medicines Directorate (VMD) website where you can search for the product and see the most up to date Summary of product characteristics (SPC)

For FEI Advice, click here.